interviews
Click here to read the article, and here to visit Adura’s website.
Read MoreI recently enjoyed the New York Times story, Shots Fired, Pinpointed and Argued Over, featuring Erica Goode’s account of the ShotSpotter gunshot detection system in action. The article does a great job of calling attention to the success of the company’s collaboration with police forces, which in turn is creating safer communities. For instance, less […]
Read MoreOn February 22, I had the pleasure of speaking with Douglas Crawford, the associate director of QB3 the California Institute for Quantitative Biosciences in Berkeley –. It was quite exciting to be the first guest on their new podcast, QB3 Bio Entrepreneurship. During our lively hour discussion, I had the opportunity to share my thoughts on […]
Read MoreDecember 12, 2011 source: originally published at Pessimism about the clean tech space has been on the rise recently, thanks in part to a pair of high profile failures of government-backed companies. Congress and the media have pounced on the carrion like starving scavengers. In the frenzy of sensationalism, it is hard for the public […]
Read MoreSam Coates is a partner at Cooley, and a great friend and colleague of mine. He wrote this blog post just for us. Money, motorcycle racing and startups—it’s all about winning and losing Guest Post by Sam Coates “I like money,” one founder said to me bluntly, in response to my question about what […]
Read More
October 9, 2011 source: CBS News As part of CBS morning news, TIBION was profiled by correspondent Barry Peterson. At approximately four minutes 21 seconds into the video, see how TIBION stands out. We are proud of our portfolio company that is getting worldwide recognition. The next step in bionics … The new world of […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.